quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:09·1614d
SECFiling
Trillium Therapeutics Inc. logo

SEC Form EFFECT filed by Trillium Therapeutics Inc.

TRIL· Trillium Therapeutics Inc.
Health Care
Original source

Companies

  • TRIL
    Trillium Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 17UpdateThe Benchmark Company-
  • Nov 17UpdateBenchmark-
  • Aug 24UpdateCraig-Hallum$18.50
  • Aug 24UpdateJMP Securities-
  • Aug 23UpdateHC Wainwright & Co.$18.50

Related

  • PR97d
    Defiance ETFs Announces Closure of Select Funds
  • PR205d
    Defiance Launches $TRIL – The Trillion Dollar Club ETF: The New "Magnificent 7" of Global Markets
  • NEWS1142d
    Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
  • NEWS1401d
    10 Psychedelics CEOs To Pay Attention To In 2022
  • PR1406d
    Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders and Appoints James T. Parsons to its Board of Directors
  • SEC1606d
    SEC Form 15-12B filed by Trillium Therapeutics Inc.
  • SEC1614d
    SEC Form EFFECT filed by Trillium Therapeutics Inc.
  • INSIDER1616d
    SEC Form 4: Walker Paul Edward returned 5,736,363 shares to the company
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022